Skip to content

Haven Health

Haven Health, Inc. was a medical technology company that grew out of Project Haven—a Johns Hopkins University research initiative that produced the first integrated contactless home monitoring system for medically complex individuals during sleep. The company represented something rare in the medtech industry: a for-profit entity whose founding philosophy, product design, and business model were shaped from inception by the people the product was built to serve. Haven Health was not a company that consulted disabled people after the engineering was done. It was a company that existed because a disabled man sat in a meeting and said the engineering was wrong, and the engineers listened.

Overview

Haven Health occupied a market category it had essentially created: medical-grade home monitoring systems designed for people with complex, intersecting disabilities who could not tolerate wearable devices and whose caregivers needed unified, intelligent alerting rather than a drawer full of disconnected monitors. The company's flagship product, the Haven Home System, integrated contactless radar sensing, AI-powered movement analysis, environmental monitoring, and CPAP data stream integration into a single platform with a unified caregiver dashboard. Optional accessories—the Haven Band, Pad, Clip, Go, and Pack—extended the ecosystem for users with varying needs, tolerances, and levels of independence.

The company was headquartered in Baltimore, Maryland—a deliberate choice that reflected both its Johns Hopkins origins and Logan Weston's insistence that the company remain rooted in the community where the research began rather than relocating to a coastal tech hub where proximity to venture capital would have been convenient and proximity to the patient population would have been lost.

Founding and History

From Research to Company (~2028–2034)

Project Haven originated around 2028–2029 as a collaboration between the Johns Hopkins Department of Biomedical Engineering and the Department of Neurology's epilepsy division, focused on reducing SUDEP (Sudden Unexpected Death in Epilepsy) risk through continuous contactless home monitoring. The project's clinical validation phase, which included volunteer testing by Charlie Rivera, Jacob Keller, and Riley Mercer, demonstrated both the system's clinical viability and a market need that no existing company was serving.

The decision to spin off into an independent company rather than license the technology to an established medtech firm was driven by a shared conviction among the research team that Haven's design philosophy would not survive acquisition. The product's core values—contactless-first design, disability-informed engineering, caregiver-centered alerting, multi-unit portability, accessible interfaces, and HIPAA-from-inception data architecture—were not features that could be preserved à la carte. They were an integrated philosophy that required organizational control to maintain. A larger company would have kept the radar sensor and cut the wheelchair-mountable travel bag. A larger company would have shipped with a single-room deployment model because multi-unit architecture was more expensive to support. A larger company would have treated the customizable sparkly pink armband as a frivolous SKU rather than an expression of the principle that medical devices should be something people wanted to wear, not something they endured.

Haven Health, Inc. was incorporated as a Public Benefit Corporation—a legal structure that required the company to consider the impact of its decisions on its stated public benefit mission alongside shareholder returns. This was not a symbolic gesture. It was a structural protection against the drift that turned mission-driven startups into margin-driven corporations. The stated public benefit: improving the safety, autonomy, and dignity of medically complex individuals through accessible, affordable home monitoring technology.

Early Funding and Growth

Initial funding came from a combination of NIH Small Business Innovation Research (SBIR) grants, Johns Hopkins Technology Ventures (the university's commercialization arm), and a seed round from impact investors whose thesis centered on healthcare equity. The company deliberately avoided venture capital firms whose return expectations would have pressured rapid scaling at the expense of the slow, careful product refinement that medical devices required—and that Haven's patient population deserved.

Hopkins retained a licensing relationship and ongoing research partnership, providing Haven Health with continued access to clinical validation infrastructure, neurology department collaboration, and the institutional credibility that mattered when navigating FDA clearance and insurance reimbursement pathways. The relationship was mutually beneficial: Hopkins gained a commercialization success story and ongoing research data from deployed units, and Haven gained the clinical authority that only a top-tier academic medical center could provide.

Products, Services, and Business Model

Product Line

Haven Health's product ecosystem centered on the Haven Home System (the room unit, caregiver dashboard, and app) with five optional accessories: the Haven Band (wearable armband for continuous biometric monitoring), the Haven Pad (under-mattress pressure sensor), the Haven Clip (portable pulse oximeter for acute illness), the Haven Go (battery-powered travel unit), and the Haven Pack (wheelchair-mountable travel and storage bag). For full technical specifications and product details, see Project Haven - Home Monitoring System.

Pricing Model

Logan Weston's position on pricing was unequivocal: a monitoring system that only wealthy families could afford was a monitoring system that allowed poor disabled people to die. The pricing model reflected this conviction through multiple access pathways designed to ensure that cost was never the reason a medically complex person went unmonitored.

Insurance Reimbursement (Primary Pathway): Haven pursued and obtained coverage classification as a durable medical equipment (DME) device eligible for reimbursement through Medicare, Medicaid, and major private insurers. The FDA clearance process—which Haven navigated with clinical data from the Hopkins validation phase—established the system as a medical device rather than a consumer wellness product, which was the critical regulatory distinction that enabled insurance billing. For users whose insurance covered the device, out-of-pocket cost was limited to copays and deductibles. Logan's team worked specifically with Medicaid programs in states with large disabled populations to ensure that the people who most needed Haven and could least afford it had a reimbursement pathway.

Sliding-Scale Direct Purchase: For users who fell outside insurance coverage—people between plans, people whose insurers denied the claim, people in states with inadequate Medicaid coverage, people whose immigration status excluded them from public insurance—Haven offered a sliding-scale pricing model based on household income. The scale was not performative. The lowest tier was genuinely affordable, subsidized by the margins on full-price sales and by the company's grant funding. The application process was simple and did not require financial documentation beyond self-reported income, because the company understood that the people who needed the sliding scale were also the people least likely to have organized financial records and most likely to be deterred by an invasive application process.

Grant-Funded Unit Placement: Haven Health maintained a grant-funded program that placed units at no cost in households identified by partner organizations—disability service agencies, epilepsy foundations, community health centers, and residential care facilities. These placements were funded through a combination of foundation grants, corporate social responsibility partnerships, and a portion of full-price revenue allocated to the program. The units were not charity—they were the same product, with the same features, the same support, and the same data integration. The only difference was who paid.

Institutional Licensing: Residential care facilities, group homes, hospitals, and respite care programs could license Haven systems for multi-room deployment at institutional rates. This pathway was particularly important for the population Haven was originally designed to serve: people with severe epilepsy and intellectual disabilities living in residential settings, where the risk of SUDEP was highest and the existing monitoring infrastructure was often decades behind the technology available to people living independently.

The pricing model was not universally popular with investors. Impact investors understood it. Traditional medtech investors found the sliding scale and grant-funded placements difficult to reconcile with growth projections. Haven's response, articulated by the CEO in investor communications, was consistent: the company existed to serve a population the market had ignored. If the margins were lower than a pure commercial play, the mission was the reason the company existed, and the Public Benefit Corporation structure meant the mission was not negotiable.

Founding Philosophy and Business Identity

Haven Health's identity was built on a set of principles that emerged from the research phase and hardened into company values during incorporation. These were not marketing copy. They were design constraints that shaped every product decision, every hiring choice, and every partnership the company pursued.

"Nothing about us without us." The disability rights movement's foundational principle was Haven's operational reality. The company's clinical advisory board included disabled people. The user testing program centered disabled users and their caregivers. Product decisions were reviewed by people who would actually use the product, not by focus groups assembled to validate decisions already made. Logan Weston's presence on the leadership team was the most visible expression of this principle, but it extended throughout the organization—Haven hired disabled engineers, disabled designers, disabled customer support staff, not as tokens but as people whose lived experience made them better at their jobs.

"The system follows the person." Haven's multi-unit architecture—the principle Logan articulated as "if it only works in one room, it's not a haven, it's a cage"—was not just a product feature. It was a business philosophy. Disabled people moved through the world. They visited family. They traveled. They were hospitalized. They went to respite care. A monitoring system that anchored them to one room was a monitoring system that restricted their freedom in the name of protecting their safety, and Haven rejected that trade-off.

"Your data belongs to you." Haven's HIPAA-compliant, user-controlled data architecture was a direct response to the medtech industry's standard practice of treating patient data as a corporate asset. Haven users owned their data. They controlled where it went. They could export it, share it with any provider, revoke access at any time, and delete their historical records if they chose. The company did not sell user data, did not use it for advertising, and did not share it with third parties without explicit, granular, revocable consent. Logan's insistence on this principle came from understanding that disabled people's medical data had historically been weaponized—by insurers denying coverage, by employers making hiring decisions, by institutions justifying involuntary treatment. Privacy was not a feature. It was protection.

"Medical devices should be wanted, not endured." The customizable Haven Band, the neutral colorways of the room unit, the day-bag aesthetic of the Haven Pack, the silent-by-default operating mode—all of these reflected a conviction that medical equipment did not have to look, sound, or feel like medical equipment. The people who used Haven already carried enough visible markers of their medical lives. The monitoring system they depended on did not need to add another one. Sofia Medina's sparkly pink armband was not an edge case. It was the design philosophy made tangible: a device that a woman wore because she wanted to, not because she had to.

"This tool supplements your attention. It does not replace it." Haven's distress inference feature—the AI-driven pain detection module—carried this warning on its activation screen because Logan insisted it appear there, not buried in settings. The principle extended beyond a single feature. Haven was a tool. It provided data. It flagged anomalies. It carried a mother's voice from the kitchen to the guest room. But it did not replace the mother, the brother, the caregiver, the partner. The system's purpose was to make caregiving more informed, not to make caregivers unnecessary. This distinction mattered because the medtech industry's implicit promise—that technology could replace human attention—was a promise that failed the people who needed human attention most.

Workplace Culture and Staff

Founders and Senior Leadership

The CEO and co-founder, Samir Panda, was the postdoc who conceived Haven and led the original Hopkins research team, and who recruited Logan Weston during his early med school years. Samir brought the engineering vision, the research credibility, and the business acumen that translated a university project into a viable company. His framing of Logan's initial invitation—"the door is open and it stays open regardless of how far you walk through it"—established the leadership culture that defined the company: rigorous, respectful, and genuinely committed to shared authority rather than hierarchical decision-making.

Logan Weston — Chief Medical Officer / Founding Clinical Advisor

Logan's role at Haven Health evolved through three phases that mirrored his medical career. During the research phase (~2030–2034), he served as a clinical research advisor—a med student contributing design insights that redirected the project's engineering approach. When the company incorporated (~2034), Logan joined the founding advisory board as Chief Clinical Advisor, shaping company direction and product philosophy without operational responsibility. As his clinical career matured—the Weston Centers established, his reputation in neurorehabilitation and pain medicine solidified, his publications and teaching creating institutional authority—his Haven role deepened into Chief Medical Officer: the person who ensured the product's clinical integrity, reviewed research partnerships, signed off on new features including the distress inference module, and represented the company in clinical and regulatory contexts.

Logan never sought centrality at Haven. He showed up. He contributed. The work needed him. Over time the role grew to match the contribution, not the other way around. His involvement was not executive—he did not manage staff, did not attend operational meetings, did not review quarterly financials. His involvement was philosophical and clinical: every product decision that affected how the system interacted with a human body, a caregiver's workflow, or a user's dignity passed through Logan's review. The company needed his clinical authority and his lived-experience compass. He needed the company to keep making a product that reflected what he believed medical technology should be. The relationship worked because neither party tried to be the other.

Logan's Haven work ran alongside his clinical career at Hopkins and later at the Weston Centers—board calls on Friday mornings, clinical validation protocol reviews on weekends, the occasional keynote at a medtech conference where he delivered Haven's philosophy from his wheelchair with the same clinical precision he brought to everything else. Charlie Rivera, who had been a Haven tester before he was a Haven advisor's partner, understood that this work mattered to Logan in a way that was distinct from but inseparable from his clinical practice. Both were about the same thing: making sure disabled people were seen, believed, and served by the systems that were supposed to help them.

Disability, Accessibility, and Inclusion

Haven Health was not a company that accommodated disabled employees. It was a company built by and for disabled people, and its internal practices reflected that origin. The offices were wheelchair-accessible not because of ADA compliance but because the Chief Medical Officer used a wheelchair and the company would have been absurd to build spaces he couldn't navigate. The internal communication tools were screen-reader compatible not because of WCAG guidelines but because the company served blind and low-vision users and employed staff who used screen readers. Flexible scheduling existed not as a perk but as recognition that many staff members—including the CMO—managed chronic conditions that did not respect nine-to-five schedules.

The company's hiring practices prioritized competence and mission alignment, and the result was a workforce with a significantly higher proportion of disabled employees than the medtech industry average. This was not a quota. It was a natural outcome of building a company whose mission attracted disabled people and whose culture did not penalize them for the accommodations their bodies required. The sparkly pink armband and the wheelchair-mountable Pack did not come from an accessibility consultant's report. They came from people who lived in the bodies the product was designed to serve.

Public Reputation and Industry Standing

Haven Health's reputation in the medtech industry was defined by a tension the company embraced rather than resolved: it was simultaneously respected for its clinical rigor and regarded with skepticism by competitors who found its pricing model unsustainable, its design philosophy idealistic, and its refusal to prioritize shareholder returns over patient access naive. The clinical data was difficult to argue with—Haven's seizure detection sensitivity and SUDEP prevention outcomes exceeded those of wearable-only competitors, and the caregiver satisfaction metrics were among the highest in the home monitoring category. The business model was easier to criticize, and competitors did.

Among the disability community—the users, the caregivers, the advocates—Haven's reputation was something closer to devotion. The company had built a product that worked for people the industry had ignored, priced it so that poverty was not a death sentence, and designed it so that using it didn't feel like being surveilled. For families who had spent years cobbling together inadequate monitoring solutions from baby monitors and consumer pulse oximeters, Haven was not just a better product. It was evidence that someone had finally listened.

Logan Weston's association with the company carried specific weight. His name—already known in neurology and disability medicine circles through the Weston Centers and his teaching career—lent Haven a clinical credibility that pure-engineering medtech startups couldn't match. When Logan spoke about Haven at conferences, he spoke not as a spokesperson but as a physician who had helped build a product he also recommended to his patients. The conflict of interest was disclosed, transparent, and ultimately irrelevant, because Logan's clinical reputation was built on a foundation of honesty that no one who knew him questioned.

Legacy and Impact

Haven Health's legacy extended beyond its product line. The company demonstrated that disability-informed design was not a niche market strategy but a design philosophy that produced better products for everyone. The contactless monitoring approach that Logan championed because wearables failed sensory-sensitive users turned out to produce better data for all users, because nobody slept well with a device strapped to their wrist. The multi-unit architecture that Logan demanded because disabled people didn't stay in one room turned out to be the feature that drove adoption among elderly users whose families wanted monitoring in both the bedroom and the living room. The accessible app that Haven built because their users needed screen readers turned out to be easier for every caregiver to use at 3 AM when exhaustion made fine motor control unreliable.

The lesson Haven taught the medtech industry—slowly, reluctantly, against significant resistance—was that designing for the most complex user produced solutions that worked for everyone. The industry called this "universal design." Logan called it "doing the job right the first time."

For the Medina family, Haven Health was not a company. It was the system that let Claudia cook dinner while Sofia napped, that told Cisco whether to check or to run, that carried a mother's voice from the kitchen to the guest room when a woman who could not be left alone woke up and called for someone. The company's mission statement lived on a website. Its purpose lived in a carriage house in Brooklyn, on a shelf in a guest room, pulsing a slow muted teal in the dark.

Organizations Businesses Medical Technology Haven Health Samir Panda Logan Weston